Mpox (formerly Monkeypox), a neglected tropical disease once confined to Central and West
Africa, emerged as a global epidemic outbreak in May, 2022 with 87,529 cases reported as …

Background Although the recent literature indicates that mpox (monkeypox) primarily affects
men, there are also multiple reports in women. Estimates of the sex distribution of mpox …

Summary The World Health Organization declared mpox a public health emergency of
international concern in July 2022. To investigate global mpox transmission and population …

Introduction During the 2022 mpox outbreak, the province of Quebec, Canada, prioritized
first doses for pre-exposure vaccination of people at high mpox risk, delaying second doses …

Background In 2022, there were outbreaks of Mpox where the disease is not endemic. We
summarized published full-text epidemiological data from the outbreaks. Methods A global …

Mpox virus infection is a significant public health concern worldwide due to its potential
severity and the likelihood of outbreaks occurring across different regions. Ophthalmic …

The human monkeypox virus (MPXV) was the etiologic agent of the 2022–2023 monkeypox
(mpox) pandemic. Although PCR assays were rapidly available to diagnosed mpox for …

MVA-BN is an orthopoxvirus vaccine that provides protection against both smallpox and
mpox. In June 2022, Canada launched a publicly-funded vaccination campaign to offer MVA …

In 2022, while the world has yet to be free from the aftermath of the long-term pandemic
caused by COVID-19, the unusual epidemic of endemic diseases in Africa called mpox …

Abstract Purpose of Review The 2022 global mpox outbreak is a significant public health
challenge. This review provides a summary of recent advancements in mpox phylogenetics …